Actively Recruiting
Anti-aging Efficacy Study on One Cosmetic Product Containing Mitopure
Led by Amazentis SA · Updated on 2026-04-29
30
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
Sponsors
A
Amazentis SA
Lead Sponsor
S
SGS proderm GmbH
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to investigate the impact of a topical product on skin health and aging
CONDITIONS
Official Title
Anti-aging Efficacy Study on One Cosmetic Product Containing Mitopure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written Informed Consent to participate in the study
- Written Informed Consent for the use of the images for marketing purposes applies to subgroup participants of study 26.0112.
- Willingness to actively participate in the study and to come to the scheduled visits
- Female
- Male, approximately 10 to 15% with little facial hair
- From 45 to 65 years of age
- Healthy skin in the test areas
- Visible wrinkles in the face (grade 3 to 6 according to proderm wrinkle score)
You will not qualify if you...
- Female participants: Pregnancy or lactation
- Drug addicts, alcoholics
- AIDS, HIV-positive or infectious hepatitis
- Conditions which exclude a participation or might influence the test reaction/evaluation
- Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
- Active skin disease at the test area
- Documented allergies to face/eye care products or their ingredients
- Diabetes mellitus
- Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
- One of the following illnesses with reduced physical capability/fitness: asthma (symptom-free allergic asthma is not an exclusion criterion), hypertension (if not adjusted with medication), cardiovascular diseases
- Epilepsy
- Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, freckles, etc. at the test area that could influence the investigation
- Regular use of tanning beds within the last 6 weeks prior to the start of the study
- Any topical medication at the test area within the last 3 days prior to the start of the study
- Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) within the last 7 days prior to the start of the study and throughout the entire course of the study that in the opinion of the investigator may affect the outcome of the study
- Therapy with antibiotics within the last 2 weeks prior to the start of the study and throughout the entire course of the study that in the opinion of the investigator may affect the outcome of the study
- Cosmetic surgery procedure in the test area (e.g. laser, facelift) within the last 2 years and throughout the entire course of the study
- Cosmetic surgery treatments in the test area, e.g. IPL (Intensed Pulsed Light), botox, chemical peel, dermabrasion within the last 2 years prior to the start of the study and throughout the entire course of the study
- Medical treatment for wrinkle reduction (e.g. peeling with vitamin A or fruit acids) on the face within the last 2 weeks prior to the start of the study and throughout the entire course of the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
SGS proderm GmbH
Schenefeld, Germany, 22869
Actively Recruiting
Research Team
B
Brad Currier, PhD
CONTACT
A
Anurag Singh, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here